China Medical System to pay Insilico up to about $177 million for central nervous system work
13/07/2026 02:53
China Medical System to pay Insilico up to about $177 million for central nervous system work SHANGHAI, July 13 (Reuters) - Chinese drugmaker China Medical System 0867.HK will pay Insilico Medicine 03696.HK up to about 1.2 billion yuan ($177 million) in payments linked to milestones for work on a research and development programme in the central nervous system disease field, the Boston-based drug discovery firm said.
(Reporting by Andrew Silver in Shanghai; Editing by Jacqueline Wong)
Recent news on China Medical System Holdings
See all newsBrief: China Medical System Says CMS-D001 Granted Drug Clinical Trial Approval Notice By NMPA
Brief: China Medical System Holdings Says Dermavon Receives NMPA Approval For Lumirix NDA For Atopic Dermatitis
China Medical System climbs most in six weeks on higher profit, dividend
China Medical System H1 revenue rises on jump in sales of innovative and exclusive products
AI shortens drug discovery to around 1 year in China, Insilico CEO says